Back to Search
JAVIER PINILLA-IBARZ, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1487736856IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
ME97234(FL)
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
ME97234(FL)
Education
OTHER
Class of 1990
Research & Publications (20)
The biological basis for immunotherapy in patients with chronic myelogenous leukemia.
PMID 19337200·Cancer Control·2009
6-review
Modern approaches to treating chronic myelogenous leukemia.
PMID 18706263·Curr Oncol Rep·2008
6-review
Treatment of chronic lymphocytic leukemia with a hypomethylating agent induces expression of NXF2, an immunogenic cancer testis antigen.
PMID 19401350·Clin Cancer Res·2009
8-other
Signaling networks associated with BCR-ABL-dependent transformation.
PMID 19337196·Cancer Control·2009
6-review
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy.
PMID 19295545·Leukemia·2009
8-other
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.
PMID 19011628·Nat Immunol·2009
7-preclinical
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance.
PMID 18852120·Mol Cancer Ther·2008
8-other
Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
PMID 18618518·Cancer·2008
6-review
A case of acute basophilic leukemia arising from chronic myelogenous leukemia with development of t(7;8)(q32;q13).
PMID 18328951·Cancer Genet Cytogenet·2008
5-case
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease.
PMID 18256684·Leukemia·2008
8-other
Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
PMID 17671141·Clin Cancer Res·2007
8-other
Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein.
PMID 16990779·Leukemia·2006
8-other
Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules.
PMID 16533527·Leuk Res·2006
8-other
Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.
PMID 16269613·Blood·2006
7-preclinical
Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responses.
PMID 16219568·Haematologica·2005
4-observational
Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
PMID 15197237·J Leukoc Biol·2004
8-other
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia.
PMID 14504104·Blood·2004
3-trial
Novel targeted and immunotherapeutic strategies in chronic myeloid leukemia.
PMID 12563615·Semin Hematol·2003
6-review
Vaccination with CD20 peptides induces a biologically active, specific immune response in mice.
PMID 11986232·Blood·2002
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12902 USF MAGNOLIA DR, MRC 3 EAST RM 3056H
TAMPA, FL 33612 - Phone
- (813) 745-4748
Quick Facts
- NPI
- 1487736856
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile